May 25, 2024, 08:53
Sergio Cifuentes: Key potential insights in immunotherapy of maintenance in women with high T-cell Clonality
Sergio Cifuentes, Student Fellow at National Autonomous University of Mexico, shared on X:
“Maintenance Pembrolizumab for HER2- mBC.
– 43 women (32 TNBC): CR, PR, or SD after 3 cycles of chemotherapy,
– 4m DCR: 58.1%,
– mPFS: 4.8 m,
– T-cell Clonality: PFS 10.4 vs. 3.6.
Key potential insights in immunotherapy of maintenance in women with high T-cell Clonality.”
Proceed to the article.
Source: Sergio Cifuentes/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 21, 2025, 20:46
Apr 21, 2025, 20:30
Apr 21, 2025, 20:11
Apr 21, 2025, 19:55
Apr 21, 2025, 19:12
Apr 21, 2025, 18:19
Apr 21, 2025, 18:00
Apr 21, 2025, 17:40
Apr 21, 2025, 17:35
Apr 21, 2025, 17:29